These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35026672)

  • 1. A parallel-group study of near-infrared spectroscopy-neurofeedback in children with attention deficit hyperactivity disorder.
    Wu WJ; Cui LB; Cai M; Peng ZW; Zhang WC; Lv S; Xu JY; Hu Y; Li G; von Deneen KM; Zhu CZ; Wang HN; Zhang Y
    Psychiatry Res; 2022 Mar; 309():114364. PubMed ID: 35026672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIRS-based neurofeedback training in a virtual reality classroom for children with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial.
    Blume F; Hudak J; Dresler T; Ehlis AC; Kühnhausen J; Renner TJ; Gawrilow C
    Trials; 2017 Jan; 18(1):41. PubMed ID: 28118856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared spectroscopy (NIRS) neurofeedback as a treatment for children with attention deficit hyperactivity disorder (ADHD)-a pilot study.
    Marx AM; Ehlis AC; Furdea A; Holtmann M; Banaschewski T; Brandeis D; Rothenberger A; Gevensleben H; Freitag CM; Fuchsenberger Y; Fallgatter AJ; Strehl U
    Front Hum Neurosci; 2014; 8():1038. PubMed ID: 25610390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
    Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
    Ota T; Iida J; Nakanishi Y; Sawada S; Matsuura H; Yamamuro K; Ueda S; Uratani M; Kishimoto N; Negoro H; Kishimoto T
    Psychiatry Clin Neurosci; 2015 Mar; 69(3):161-70. PubMed ID: 25359429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.
    Arnold LE; Ober N; Aman MG; Handen B; Smith T; Pan X; Hyman SL; Hollway J; Lecavalier L; Page K; Rice R
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):322-330. PubMed ID: 29694241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG Neurofeedback Training in Children With Attention Deficit/Hyperactivity Disorder: A Cognitive and Behavioral Outcome Study.
    Shereena EA; Gupta RK; Bennett CN; Sagar KJV; Rajeswaran J
    Clin EEG Neurosci; 2019 Jul; 50(4):242-255. PubMed ID: 30453757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Near-Infrared Spectroscopy (NIRS) for evaluating drug effects and improvements in medication adherence in children with Attention Deficit Hyperactivity Disorder (ADHD).
    Kawai C; Mori K; Tanioka T; Betriana F; Mori K; Mori T; Ito H
    J Med Invest; 2021; 68(1.2):53-58. PubMed ID: 33994480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.
    Smith T; Aman MG; Arnold LE; Silverman LB; Lecavalier L; Hollway J; Tumuluru R; Hyman SL; Buchan-Page KA; Hellings J; Rice RR; Brown NV; Pan X; Handen BL
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):868-876.e2. PubMed ID: 27663942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Atomoxetine on the Cognitive Functions in Treatment of Attention Deficit Hyperactivity Disorder in Children with Congenital Hypothyroidism: A Pilot Study.
    Yang R; Gao W; Li R; Zhao Z
    Int J Neuropsychopharmacol; 2015 Apr; 18(8):. PubMed ID: 25896257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofeedback and cognitive attention training for children with attention-deficit hyperactivity disorder in schools.
    Steiner NJ; Frenette EC; Rene KM; Brennan RT; Perrin EC
    J Dev Behav Pediatr; 2014 Jan; 35(1):18-27. PubMed ID: 24399101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
    De Bruyckere K; Bushe C; Bartel C; Berggren L; Kan CC; Dittmann RW
    CNS Drugs; 2016 Jun; 30(6):541-58. PubMed ID: 27224994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
    Handen BL; Aman MG; Arnold LE; Hyman SL; Tumuluru RV; Lecavalier L; Corbett-Dick P; Pan X; Hollway JA; Buchan-Page KA; Silverman LB; Brown NV; Rice RR; Hellings J; Mruzek DW; McAuliffe-Bellin S; Hurt EA; Ryan MM; Levato L; Smith T
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):905-15. PubMed ID: 26506581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
    Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
    Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Offering Neurofeedback as an Intervention for Children with Attention Deficit/Hyperactivity Disorder in Indonesia: A Feasibility Study.
    Subandriyo APEP; Jongsma MLA; Wijaya DA; Trisnadewi BAP; Paravoti A; Novihartanti BL; Widyorini E; Sulastri A; Breteler MHM
    Kobe J Med Sci; 2021 Dec; 67(4):E125-E136. PubMed ID: 35367999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.